The rate of dyslipidemia is higher in patients on peritoneal dialysis, driven by increased lipoprotein synthesis in the liver due to glucose absorption from the dialysis solution, which increases insulin levels and protein loss (42, 43). Here, INS is linked to metabolic syndrome.